The Institute of Quantitative Health Science and Engineering at Michigan State University will be hosting a symposium entitled, “Oncogenomic Tenets of Precision Oncology” on November 12-13.
Aimed at an audience of undergraduate students to professionals in the fields of genomics and cancer, the symposium will provide an opportunity for academics and representatives from industry to connect and have open discussions about the field of oncogenomics and its impact on clinical care.
The symposium’s first day will consist of an industry technical showcase by PerkinElmer, DNANexus, and Qiagen. The second day will include talks by various academics and industry professionals followed by a tour of the Facility for Rare Isotope Beams.
“This year we hope to extend our research further, build durable corporate and clinical partnerships and break down the health and medicine barriers that limit us from ensuring 100 years of health for 100 percent of our population. These objectives will enhance our research mission that extends 'From first ever… to first in humans,' says Chris Contag, director of the Institute of Quantitative Health Science and Engineering.
Registration for the event is free, but required in order to attend. Go to the EventBrite site to register.